2D miR_HR1_12
Gene Symbol | Gene ID | Gene Info |
---|---|---|
Tlx2
|
ENSMUSG00000068327.3 | T cell leukemia, homeobox 2 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Tlx2 | mm10_v2_chr6_-_83070225_83070377 | -0.41 | 1.8e-01 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr3_+_90669063 | 1.25 |
ENSMUST00000069927.8
|
S100a8
|
S100 calcium binding protein A8 (calgranulin A) |
chr3_-_90695706 | 1.07 |
ENSMUST00000069960.5
ENSMUST00000117167.1 |
S100a9
|
S100 calcium binding protein A9 (calgranulin B) |
chr7_+_30493622 | 1.05 |
ENSMUST00000058280.6
ENSMUST00000133318.1 ENSMUST00000142575.1 ENSMUST00000131040.1 |
Prodh2
|
proline dehydrogenase (oxidase) 2 |
chr17_+_17887840 | 0.82 |
ENSMUST00000054871.5
ENSMUST00000064068.4 |
Fpr3
Fpr2
|
formyl peptide receptor 3 formyl peptide receptor 2 |
chr12_+_100779074 | 0.80 |
ENSMUST00000110073.1
ENSMUST00000110070.1 |
9030617O03Rik
|
RIKEN cDNA 9030617O03 gene |
chr7_-_46715676 | 0.78 |
ENSMUST00000006956.7
|
Saa3
|
serum amyloid A 3 |
chr5_-_137858034 | 0.77 |
ENSMUST00000110978.2
|
Pilrb1
|
paired immunoglobin-like type 2 receptor beta 1 |
chr12_+_100779088 | 0.72 |
ENSMUST00000110069.1
|
9030617O03Rik
|
RIKEN cDNA 9030617O03 gene |
chr7_-_30924169 | 0.71 |
ENSMUST00000074671.6
|
Hamp2
|
hepcidin antimicrobial peptide 2 |
chr8_+_13037802 | 0.66 |
ENSMUST00000152034.1
ENSMUST00000128418.1 |
F10
|
coagulation factor X |
chr3_-_113574758 | 0.65 |
ENSMUST00000106540.1
|
Amy1
|
amylase 1, salivary |
chr4_-_141846277 | 0.64 |
ENSMUST00000105781.1
|
Ctrc
|
chymotrypsin C (caldecrin) |
chr3_-_113574242 | 0.63 |
ENSMUST00000142505.2
|
Amy1
|
amylase 1, salivary |
chr4_-_141846359 | 0.60 |
ENSMUST00000037059.10
|
Ctrc
|
chymotrypsin C (caldecrin) |
chr15_-_100687908 | 0.59 |
ENSMUST00000023775.7
|
Cela1
|
chymotrypsin-like elastase family, member 1 |
chr4_-_4138432 | 0.58 |
ENSMUST00000070375.7
|
Penk
|
preproenkephalin |
chr6_+_117168535 | 0.58 |
ENSMUST00000112866.1
ENSMUST00000112871.1 ENSMUST00000073043.4 |
Cxcl12
|
chemokine (C-X-C motif) ligand 12 |
chr8_-_105933832 | 0.58 |
ENSMUST00000034368.6
|
Ctrl
|
chymotrypsin-like |
chr9_+_124121534 | 0.57 |
ENSMUST00000111442.1
ENSMUST00000171499.2 |
Ccr5
|
chemokine (C-C motif) receptor 5 |
chr11_+_4236411 | 0.57 |
ENSMUST00000075221.2
|
Osm
|
oncostatin M |
chr14_+_44988192 | 0.56 |
ENSMUST00000046891.5
|
Ptger2
|
prostaglandin E receptor 2 (subtype EP2) |
chr7_-_127137807 | 0.54 |
ENSMUST00000049931.5
|
Spn
|
sialophorin |
chr3_-_59130610 | 0.53 |
ENSMUST00000065220.6
ENSMUST00000091112.4 |
P2ry14
|
purinergic receptor P2Y, G-protein coupled, 14 |
chr13_-_49309217 | 0.51 |
ENSMUST00000110087.2
|
Fgd3
|
FYVE, RhoGEF and PH domain containing 3 |
chr6_+_38918969 | 0.51 |
ENSMUST00000003017.6
|
Tbxas1
|
thromboxane A synthase 1, platelet |
chr15_+_35296090 | 0.49 |
ENSMUST00000022952.4
|
Osr2
|
odd-skipped related 2 |
chr1_-_150466165 | 0.47 |
ENSMUST00000162367.1
ENSMUST00000161611.1 ENSMUST00000161320.1 ENSMUST00000159035.1 |
Prg4
|
proteoglycan 4 (megakaryocyte stimulating factor, articular superficial zone protein) |
chr2_+_165055625 | 0.47 |
ENSMUST00000017799.5
ENSMUST00000073707.2 |
Cd40
|
CD40 antigen |
chr7_+_28437447 | 0.45 |
ENSMUST00000108292.2
ENSMUST00000108289.1 |
Gmfg
|
glia maturation factor, gamma |
chr16_-_3718105 | 0.44 |
ENSMUST00000023180.7
ENSMUST00000100222.2 |
Mefv
|
Mediterranean fever |
chr2_-_121235689 | 0.44 |
ENSMUST00000142400.1
|
Trp53bp1
|
transformation related protein 53 binding protein 1 |
chr7_-_3915501 | 0.44 |
ENSMUST00000038176.8
ENSMUST00000090689.4 |
Lilra6
|
leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 6 |
chr2_-_176319494 | 0.42 |
ENSMUST00000108961.3
|
Gm11009
|
predicted gene 11009 |
chr10_+_79890853 | 0.41 |
ENSMUST00000061653.7
|
Cfd
|
complement factor D (adipsin) |
chr11_-_52282564 | 0.41 |
ENSMUST00000086844.3
|
Tcf7
|
transcription factor 7, T cell specific |
chr3_-_96293953 | 0.41 |
ENSMUST00000029748.3
|
Fcgr1
|
Fc receptor, IgG, high affinity I |
chr10_+_80016653 | 0.41 |
ENSMUST00000099501.3
|
Hmha1
|
histocompatibility (minor) HA-1 |
chr7_-_57386871 | 0.40 |
ENSMUST00000068394.6
|
Gabrg3
|
gamma-aminobutyric acid (GABA) A receptor, subunit gamma 3 |
chr17_-_31144271 | 0.40 |
ENSMUST00000024826.7
|
Tff2
|
trefoil factor 2 (spasmolytic protein 1) |
chr6_-_124636085 | 0.39 |
ENSMUST00000068797.2
|
Gm5077
|
predicted gene 5077 |
chr8_+_92827273 | 0.39 |
ENSMUST00000034187.7
|
Mmp2
|
matrix metallopeptidase 2 |
chr2_+_173659834 | 0.39 |
ENSMUST00000109110.3
|
Rab22a
|
RAB22A, member RAS oncogene family |
chr9_+_124102110 | 0.39 |
ENSMUST00000168841.1
ENSMUST00000055918.6 |
Ccr2
|
chemokine (C-C motif) receptor 2 |
chr10_-_128298084 | 0.39 |
ENSMUST00000026449.1
|
Il23a
|
interleukin 23, alpha subunit p19 |
chr4_+_155469114 | 0.38 |
ENSMUST00000178188.1
ENSMUST00000178238.1 ENSMUST00000023920.2 |
Tmem52
|
transmembrane protein 52 |
chr11_-_115027012 | 0.38 |
ENSMUST00000100240.2
|
Gm11710
|
predicted gene 11710 |
chr8_+_104340594 | 0.38 |
ENSMUST00000034343.4
|
Cmtm3
|
CKLF-like MARVEL transmembrane domain containing 3 |
chr11_+_95837216 | 0.38 |
ENSMUST00000107712.1
|
Gngt2
|
guanine nucleotide binding protein (G protein), gamma transducing activity polypeptide 2 |
chr8_-_111691002 | 0.37 |
ENSMUST00000034435.5
|
Ctrb1
|
chymotrypsinogen B1 |
chr18_+_60376029 | 0.37 |
ENSMUST00000066912.5
ENSMUST00000032473.6 |
Iigp1
|
interferon inducible GTPase 1 |
chrX_-_155623325 | 0.36 |
ENSMUST00000038665.5
|
Ptchd1
|
patched domain containing 1 |
chr9_+_108080436 | 0.36 |
ENSMUST00000035211.7
ENSMUST00000162886.1 |
Mst1
|
macrophage stimulating 1 (hepatocyte growth factor-like) |
chr2_+_173659760 | 0.36 |
ENSMUST00000029024.3
|
Rab22a
|
RAB22A, member RAS oncogene family |
chr17_+_35194502 | 0.36 |
ENSMUST00000173600.1
|
Ltb
|
lymphotoxin B |
chr6_+_78405148 | 0.35 |
ENSMUST00000023906.2
|
Reg2
|
regenerating islet-derived 2 |
chr4_+_148643317 | 0.35 |
ENSMUST00000105698.2
|
Gm572
|
predicted gene 572 |
chr4_-_99654983 | 0.35 |
ENSMUST00000136525.1
|
Gm12688
|
predicted gene 12688 |
chr8_-_122551316 | 0.34 |
ENSMUST00000067252.7
|
Piezo1
|
piezo-type mechanosensitive ion channel component 1 |
chr17_+_35194405 | 0.34 |
ENSMUST00000025262.5
|
Ltb
|
lymphotoxin B |
chr4_-_46138667 | 0.34 |
ENSMUST00000147837.1
|
Tstd2
|
thiosulfate sulfurtransferase (rhodanese)-like domain containing 2 |
chr7_-_141016892 | 0.34 |
ENSMUST00000081924.3
|
Ifitm6
|
interferon induced transmembrane protein 6 |
chr2_-_30903255 | 0.33 |
ENSMUST00000102852.3
|
Ptges
|
prostaglandin E synthase |
chr14_+_32785963 | 0.33 |
ENSMUST00000039191.6
|
1810011H11Rik
|
RIKEN cDNA 1810011H11 gene |
chr5_-_137871739 | 0.33 |
ENSMUST00000164886.1
|
Pilrb2
|
paired immunoglobin-like type 2 receptor beta 2 |
chr2_-_126499839 | 0.33 |
ENSMUST00000040128.5
|
Atp8b4
|
ATPase, class I, type 8B, member 4 |
chr11_-_115133981 | 0.32 |
ENSMUST00000106561.1
ENSMUST00000051264.7 ENSMUST00000106562.2 |
Cd300lf
|
CD300 antigen like family member F |
chr4_+_135728116 | 0.32 |
ENSMUST00000102546.3
|
Il22ra1
|
interleukin 22 receptor, alpha 1 |
chr17_+_35439155 | 0.31 |
ENSMUST00000071951.6
ENSMUST00000078205.7 ENSMUST00000116598.3 ENSMUST00000076256.7 |
H2-Q7
|
histocompatibility 2, Q region locus 7 |
chr9_-_48605147 | 0.31 |
ENSMUST00000034808.5
ENSMUST00000119426.1 |
Nnmt
|
nicotinamide N-methyltransferase |
chr11_+_106751255 | 0.30 |
ENSMUST00000183111.1
ENSMUST00000106794.2 |
Milr1
|
mast cell immunoglobulin like receptor 1 |
chrX_-_51205990 | 0.30 |
ENSMUST00000114876.2
|
Mbnl3
|
muscleblind-like 3 (Drosophila) |
chr9_-_103219823 | 0.30 |
ENSMUST00000168142.1
|
Trf
|
transferrin |
chr8_+_65618009 | 0.30 |
ENSMUST00000110258.1
ENSMUST00000110256.1 ENSMUST00000110255.1 |
March1
|
membrane-associated ring finger (C3HC4) 1 |
chr11_+_106751226 | 0.30 |
ENSMUST00000147326.2
ENSMUST00000182896.1 ENSMUST00000182908.1 ENSMUST00000086353.4 |
Milr1
|
mast cell immunoglobulin like receptor 1 |
chr9_-_58313189 | 0.29 |
ENSMUST00000061799.8
|
Loxl1
|
lysyl oxidase-like 1 |
chr2_+_122636962 | 0.29 |
ENSMUST00000142767.1
|
AA467197
|
expressed sequence AA467197 |
chr2_-_150668198 | 0.29 |
ENSMUST00000028944.3
|
Acss1
|
acyl-CoA synthetase short-chain family member 1 |
chr12_+_24651346 | 0.29 |
ENSMUST00000020982.5
|
Klf11
|
Kruppel-like factor 11 |
chr5_-_123141067 | 0.28 |
ENSMUST00000162697.1
ENSMUST00000160321.1 ENSMUST00000159637.1 |
AI480526
|
expressed sequence AI480526 |
chr1_-_36273425 | 0.28 |
ENSMUST00000056946.6
|
Neurl3
|
neuralized homolog 3 homolog (Drosophila) |
chr14_+_66344296 | 0.28 |
ENSMUST00000152093.1
ENSMUST00000074523.6 |
Stmn4
|
stathmin-like 4 |
chr4_-_49506538 | 0.27 |
ENSMUST00000043056.2
|
Baat
|
bile acid-Coenzyme A: amino acid N-acyltransferase |
chr17_+_34263209 | 0.27 |
ENSMUST00000040828.5
|
H2-Ab1
|
histocompatibility 2, class II antigen A, beta 1 |
chr10_+_79879614 | 0.27 |
ENSMUST00000006679.8
|
Prtn3
|
proteinase 3 |
chr1_-_162898665 | 0.27 |
ENSMUST00000111510.1
ENSMUST00000045902.6 |
Fmo2
|
flavin containing monooxygenase 2 |
chr7_-_30598863 | 0.27 |
ENSMUST00000108150.1
|
Zbtb32
|
zinc finger and BTB domain containing 32 |
chr4_-_117929466 | 0.26 |
ENSMUST00000097913.2
|
Artn
|
artemin |
chr5_-_105051047 | 0.26 |
ENSMUST00000112718.4
|
Gbp8
|
guanylate-binding protein 8 |
chr4_-_149698698 | 0.26 |
ENSMUST00000038859.7
ENSMUST00000105690.2 |
Pik3cd
|
phosphatidylinositol 3-kinase catalytic delta polypeptide |
chr2_+_136891501 | 0.26 |
ENSMUST00000141463.1
|
Slx4ip
|
SLX4 interacting protein |
chr1_-_136960427 | 0.26 |
ENSMUST00000027649.7
|
Nr5a2
|
nuclear receptor subfamily 5, group A, member 2 |
chr9_+_124101944 | 0.26 |
ENSMUST00000171719.1
|
Ccr2
|
chemokine (C-C motif) receptor 2 |
chr1_-_193370225 | 0.26 |
ENSMUST00000169907.1
|
Camk1g
|
calcium/calmodulin-dependent protein kinase I gamma |
chr5_-_62765618 | 0.25 |
ENSMUST00000159470.1
|
Arap2
|
ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 2 |
chr11_+_116593687 | 0.25 |
ENSMUST00000153476.1
|
Aanat
|
arylalkylamine N-acetyltransferase |
chr13_-_19824234 | 0.24 |
ENSMUST00000065335.2
|
Gpr141
|
G protein-coupled receptor 141 |
chrX_+_73503074 | 0.24 |
ENSMUST00000114479.1
ENSMUST00000088429.1 ENSMUST00000033744.5 |
Atp2b3
|
ATPase, Ca++ transporting, plasma membrane 3 |
chr11_-_109472611 | 0.24 |
ENSMUST00000168740.1
|
Slc16a6
|
solute carrier family 16 (monocarboxylic acid transporters), member 6 |
chr13_+_74121435 | 0.24 |
ENSMUST00000036208.6
|
Slc9a3
|
solute carrier family 9 (sodium/hydrogen exchanger), member 3 |
chr5_+_34543365 | 0.24 |
ENSMUST00000101316.3
|
Sh3bp2
|
SH3-domain binding protein 2 |
chr4_-_128962420 | 0.24 |
ENSMUST00000119354.1
ENSMUST00000106068.1 ENSMUST00000030581.3 |
Adc
|
arginine decarboxylase |
chr17_-_73950172 | 0.23 |
ENSMUST00000024866.4
|
Xdh
|
xanthine dehydrogenase |
chr3_-_88378699 | 0.23 |
ENSMUST00000098956.2
|
Bglap2
|
bone gamma-carboxyglutamate protein 2 |
chr9_-_31464238 | 0.23 |
ENSMUST00000048050.7
|
Tmem45b
|
transmembrane protein 45b |
chr13_-_49320219 | 0.23 |
ENSMUST00000110086.1
|
Fgd3
|
FYVE, RhoGEF and PH domain containing 3 |
chr7_-_126583177 | 0.23 |
ENSMUST00000098036.2
ENSMUST00000032962.4 |
Cln3
|
ceroid lipofuscinosis, neuronal 3, juvenile (Batten, Spielmeyer-Vogt disease) |
chr18_-_56925509 | 0.22 |
ENSMUST00000102912.1
|
March3
|
membrane-associated ring finger (C3HC4) 3 |
chr7_+_29170345 | 0.22 |
ENSMUST00000033886.7
|
Ggn
|
gametogenetin |
chr17_+_68837062 | 0.22 |
ENSMUST00000178545.1
|
Tmem200c
|
transmembrane protein 200C |
chr13_+_102693522 | 0.22 |
ENSMUST00000022124.3
ENSMUST00000171267.1 ENSMUST00000167144.1 ENSMUST00000170878.1 |
Cd180
|
CD180 antigen |
chr16_-_36666067 | 0.21 |
ENSMUST00000089620.4
|
Cd86
|
CD86 antigen |
chr3_-_32365643 | 0.21 |
ENSMUST00000029199.5
|
Zmat3
|
zinc finger matrin type 3 |
chr12_+_98268626 | 0.21 |
ENSMUST00000075072.4
|
Gpr65
|
G-protein coupled receptor 65 |
chr16_-_56886131 | 0.20 |
ENSMUST00000023435.5
|
Tmem45a
|
transmembrane protein 45a |
chr9_-_40984460 | 0.20 |
ENSMUST00000180872.1
|
Crtam
|
cytotoxic and regulatory T cell molecule |
chr9_+_108648720 | 0.20 |
ENSMUST00000098384.2
|
Gm10621
|
predicted gene 10621 |
chr10_-_115362191 | 0.20 |
ENSMUST00000092170.5
|
Tmem19
|
transmembrane protein 19 |
chr3_-_32365608 | 0.19 |
ENSMUST00000168566.1
|
Zmat3
|
zinc finger matrin type 3 |
chr15_+_21111452 | 0.19 |
ENSMUST00000075132.6
|
Cdh12
|
cadherin 12 |
chr19_+_56287911 | 0.19 |
ENSMUST00000095948.4
|
Habp2
|
hyaluronic acid binding protein 2 |
chr11_-_69695521 | 0.18 |
ENSMUST00000181261.1
|
Tnfsf12
|
tumor necrosis factor (ligand) superfamily, member 12 |
chr3_+_36475932 | 0.18 |
ENSMUST00000029268.6
|
1810062G17Rik
|
RIKEN cDNA 1810062G17 gene |
chr9_+_123034731 | 0.18 |
ENSMUST00000026893.4
|
Tgm4
|
transglutaminase 4 (prostate) |
chr12_+_99964499 | 0.18 |
ENSMUST00000177549.1
ENSMUST00000160413.1 ENSMUST00000162221.1 ENSMUST00000049788.8 |
Kcnk13
|
potassium channel, subfamily K, member 13 |
chr6_+_122513583 | 0.18 |
ENSMUST00000032210.7
ENSMUST00000148517.1 |
Mfap5
|
microfibrillar associated protein 5 |
chr9_-_58201705 | 0.18 |
ENSMUST00000163200.1
ENSMUST00000165276.1 |
Islr2
|
immunoglobulin superfamily containing leucine-rich repeat 2 |
chr4_-_46138398 | 0.18 |
ENSMUST00000144495.1
ENSMUST00000107770.1 ENSMUST00000156021.1 ENSMUST00000107772.1 |
Tstd2
|
thiosulfate sulfurtransferase (rhodanese)-like domain containing 2 |
chr5_+_108864833 | 0.18 |
ENSMUST00000177581.1
|
Gm10417
|
predicted gene 10417 |
chr7_-_44306903 | 0.18 |
ENSMUST00000004587.9
|
Clec11a
|
C-type lectin domain family 11, member a |
chr15_-_103340085 | 0.18 |
ENSMUST00000168828.1
|
Zfp385a
|
zinc finger protein 385A |
chr11_+_85832551 | 0.18 |
ENSMUST00000000095.6
|
Tbx2
|
T-box 2 |
chr19_-_4121536 | 0.17 |
ENSMUST00000025767.7
|
Aip
|
aryl-hydrocarbon receptor-interacting protein |
chr2_+_38511643 | 0.17 |
ENSMUST00000054234.3
ENSMUST00000112902.1 ENSMUST00000112895.1 |
Nek6
|
NIMA (never in mitosis gene a)-related expressed kinase 6 |
chr8_-_25101734 | 0.17 |
ENSMUST00000098866.4
|
Plekha2
|
pleckstrin homology domain-containing, family A (phosphoinositide binding specific) member 2 |
chr11_+_3332426 | 0.17 |
ENSMUST00000136474.1
|
Pik3ip1
|
phosphoinositide-3-kinase interacting protein 1 |
chr9_-_71771535 | 0.17 |
ENSMUST00000122065.1
ENSMUST00000121322.1 ENSMUST00000072899.2 |
Cgnl1
|
cingulin-like 1 |
chr5_-_145879857 | 0.17 |
ENSMUST00000035918.7
|
Cyp3a11
|
cytochrome P450, family 3, subfamily a, polypeptide 11 |
chr12_+_69241832 | 0.17 |
ENSMUST00000063445.6
|
Klhdc1
|
kelch domain containing 1 |
chr1_-_193370260 | 0.17 |
ENSMUST00000016323.4
|
Camk1g
|
calcium/calmodulin-dependent protein kinase I gamma |
chr10_+_41476314 | 0.17 |
ENSMUST00000119962.1
ENSMUST00000019967.9 ENSMUST00000099934.4 |
Mical1
|
microtubule associated monooxygenase, calponin and LIM domain containing 1 |
chr5_-_24601961 | 0.16 |
ENSMUST00000030791.7
|
Smarcd3
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily d, member 3 |
chr9_-_40964118 | 0.16 |
ENSMUST00000034521.7
|
4931429I11Rik
|
RIKEN cDNA 4931429I11 gene |
chr11_+_115900125 | 0.16 |
ENSMUST00000142089.1
ENSMUST00000131566.1 |
Smim5
|
small integral membrane protein 5 |
chr9_+_107399858 | 0.16 |
ENSMUST00000085092.5
ENSMUST00000164988.2 |
Cacna2d2
|
calcium channel, voltage-dependent, alpha 2/delta subunit 2 |
chr18_-_3337467 | 0.16 |
ENSMUST00000154135.1
|
Crem
|
cAMP responsive element modulator |
chr1_-_162859684 | 0.16 |
ENSMUST00000131058.1
|
Fmo1
|
flavin containing monooxygenase 1 |
chr10_+_79988584 | 0.16 |
ENSMUST00000004784.4
ENSMUST00000105374.1 |
Cnn2
|
calponin 2 |
chr15_-_99457712 | 0.16 |
ENSMUST00000161948.1
|
Nckap5l
|
NCK-associated protein 5-like |
chr8_+_121116163 | 0.16 |
ENSMUST00000054691.6
|
Foxc2
|
forkhead box C2 |
chr11_-_69921057 | 0.16 |
ENSMUST00000108609.1
ENSMUST00000108608.1 ENSMUST00000164359.1 |
Eif5a
|
eukaryotic translation initiation factor 5A |
chr7_-_12422751 | 0.16 |
ENSMUST00000080348.5
|
Zfp551
|
zinc fingr protein 551 |
chr10_+_91082940 | 0.16 |
ENSMUST00000020150.3
|
Ikbip
|
IKBKB interacting protein |
chr10_-_127621107 | 0.16 |
ENSMUST00000049149.8
|
Lrp1
|
low density lipoprotein receptor-related protein 1 |
chr1_-_139858684 | 0.16 |
ENSMUST00000094489.3
|
Cfhr2
|
complement factor H-related 2 |
chr1_-_91459254 | 0.15 |
ENSMUST00000069620.8
|
Per2
|
period circadian clock 2 |
chr6_-_147243794 | 0.15 |
ENSMUST00000153786.1
|
Gm15767
|
predicted gene 15767 |
chr17_-_23835743 | 0.15 |
ENSMUST00000059906.6
|
Prss33
|
protease, serine, 33 |
chr9_-_121839460 | 0.15 |
ENSMUST00000135986.2
|
Ccdc13
|
coiled-coil domain containing 13 |
chr11_-_4160286 | 0.15 |
ENSMUST00000093381.4
ENSMUST00000101626.2 |
Ccdc157
|
coiled-coil domain containing 157 |
chr6_+_14901440 | 0.15 |
ENSMUST00000128567.1
|
Foxp2
|
forkhead box P2 |
chr7_-_44532064 | 0.15 |
ENSMUST00000098483.2
ENSMUST00000035323.4 |
Spib
|
Spi-B transcription factor (Spi-1/PU.1 related) |
chr11_-_69920892 | 0.15 |
ENSMUST00000152589.1
ENSMUST00000108612.1 ENSMUST00000108611.1 |
Eif5a
|
eukaryotic translation initiation factor 5A |
chr18_+_20247340 | 0.15 |
ENSMUST00000054128.6
|
Dsg1c
|
desmoglein 1 gamma |
chr6_+_125215551 | 0.15 |
ENSMUST00000032487.7
ENSMUST00000100942.2 ENSMUST00000063588.8 |
Vamp1
|
vesicle-associated membrane protein 1 |
chr16_-_45693658 | 0.15 |
ENSMUST00000114562.2
ENSMUST00000036617.7 |
Tmprss7
|
transmembrane serine protease 7 |
chr7_+_131410601 | 0.15 |
ENSMUST00000015829.7
ENSMUST00000117518.1 |
Acadsb
|
acyl-Coenzyme A dehydrogenase, short/branched chain |
chr13_-_68999518 | 0.15 |
ENSMUST00000022013.7
|
Adcy2
|
adenylate cyclase 2 |
chr17_-_24632608 | 0.15 |
ENSMUST00000097373.1
|
Tsc2
|
tuberous sclerosis 2 |
chr12_-_31950170 | 0.15 |
ENSMUST00000176520.1
|
Hbp1
|
high mobility group box transcription factor 1 |
chr11_+_61022560 | 0.15 |
ENSMUST00000089184.4
|
Kcnj12
|
potassium inwardly-rectifying channel, subfamily J, member 12 |
chr2_+_151542483 | 0.15 |
ENSMUST00000044011.5
|
Fkbp1a
|
FK506 binding protein 1a |
chr11_+_44400060 | 0.15 |
ENSMUST00000102796.3
ENSMUST00000170513.1 |
Il12b
|
interleukin 12b |
chr5_+_22550391 | 0.15 |
ENSMUST00000181374.1
ENSMUST00000181764.1 ENSMUST00000181209.1 |
6030443J06Rik
|
RIKEN cDNA 6030443J06 gene |
chr4_-_149698552 | 0.14 |
ENSMUST00000134534.1
ENSMUST00000146612.1 ENSMUST00000105688.3 |
Pik3cd
|
phosphatidylinositol 3-kinase catalytic delta polypeptide |
chr12_-_31950210 | 0.14 |
ENSMUST00000176084.1
ENSMUST00000176103.1 ENSMUST00000167458.2 |
Hbp1
|
high mobility group box transcription factor 1 |
chr2_-_180954620 | 0.14 |
ENSMUST00000139929.1
|
Nkain4
|
Na+/K+ transporting ATPase interacting 4 |
chr5_+_114146525 | 0.14 |
ENSMUST00000102582.1
|
Acacb
|
acetyl-Coenzyme A carboxylase beta |
chr2_+_156008088 | 0.14 |
ENSMUST00000088650.4
|
Ergic3
|
ERGIC and golgi 3 |
chr19_+_56287943 | 0.14 |
ENSMUST00000166049.1
|
Habp2
|
hyaluronic acid binding protein 2 |
chr19_-_11266122 | 0.14 |
ENSMUST00000169159.1
|
Ms4a1
|
membrane-spanning 4-domains, subfamily A, member 1 |
chr2_-_181039160 | 0.14 |
ENSMUST00000108851.1
|
Chrna4
|
cholinergic receptor, nicotinic, alpha polypeptide 4 |
chr18_-_3281036 | 0.14 |
ENSMUST00000049942.6
ENSMUST00000139537.1 ENSMUST00000124747.1 |
Crem
|
cAMP responsive element modulator |
chr14_+_34085978 | 0.14 |
ENSMUST00000022519.8
|
Anxa8
|
annexin A8 |
chr2_+_156008045 | 0.14 |
ENSMUST00000006035.6
|
Ergic3
|
ERGIC and golgi 3 |
chr6_+_124808885 | 0.14 |
ENSMUST00000143040.1
ENSMUST00000052727.4 ENSMUST00000130160.1 |
Spsb2
|
splA/ryanodine receptor domain and SOCS box containing 2 |
chr7_+_43018798 | 0.14 |
ENSMUST00000173815.1
ENSMUST00000166914.1 |
Gm9268
|
predicted gene 9268 |
chr8_+_67494843 | 0.14 |
ENSMUST00000093470.5
ENSMUST00000163856.1 |
Nat2
|
N-acetyltransferase 2 (arylamine N-acetyltransferase) |
chr10_+_91083036 | 0.14 |
ENSMUST00000020149.5
|
Ikbip
|
IKBKB interacting protein |
chr2_-_117342949 | 0.14 |
ENSMUST00000102534.4
|
Rasgrp1
|
RAS guanyl releasing protein 1 |
chr2_-_117342831 | 0.13 |
ENSMUST00000178884.1
|
Rasgrp1
|
RAS guanyl releasing protein 1 |
chr10_+_81575499 | 0.13 |
ENSMUST00000143285.1
ENSMUST00000146358.1 |
Tle2
|
transducin-like enhancer of split 2, homolog of Drosophila E(spl) |
chr14_+_74640840 | 0.13 |
ENSMUST00000036653.3
|
Htr2a
|
5-hydroxytryptamine (serotonin) receptor 2A |
chr7_-_109438786 | 0.13 |
ENSMUST00000121748.1
|
Stk33
|
serine/threonine kinase 33 |
chr5_-_62766153 | 0.13 |
ENSMUST00000076623.4
|
Arap2
|
ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 2 |
chr4_+_134396320 | 0.13 |
ENSMUST00000105869.2
|
Pafah2
|
platelet-activating factor acetylhydrolase 2 |
chr2_-_127729872 | 0.13 |
ENSMUST00000028856.2
|
Mall
|
mal, T cell differentiation protein-like |
chr1_-_10719898 | 0.12 |
ENSMUST00000035577.6
|
Cpa6
|
carboxypeptidase A6 |
chr17_-_35980197 | 0.12 |
ENSMUST00000055454.7
|
Prr3
|
proline-rich polypeptide 3 |
chr12_-_31950535 | 0.12 |
ENSMUST00000172314.2
|
Hbp1
|
high mobility group box transcription factor 1 |
chr11_-_69695753 | 0.12 |
ENSMUST00000180946.1
|
Tnfsf12
|
tumor necrosis factor (ligand) superfamily, member 12 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.8 | 2.3 | GO:0070488 | neutrophil aggregation(GO:0070488) |
0.3 | 1.0 | GO:0010133 | proline catabolic process to glutamate(GO:0010133) |
0.2 | 0.6 | GO:2000451 | immune complex clearance by monocytes and macrophages(GO:0002436) astrocyte chemotaxis(GO:0035700) regulation of immune complex clearance by monocytes and macrophages(GO:0090264) positive regulation of immune complex clearance by monocytes and macrophages(GO:0090265) negative regulation of eosinophil activation(GO:1902567) positive regulation of CD8-positive, alpha-beta T cell extravasation(GO:2000451) regulation of astrocyte chemotaxis(GO:2000458) |
0.2 | 0.8 | GO:0097494 | regulation of vesicle size(GO:0097494) |
0.2 | 0.5 | GO:0002884 | type IV hypersensitivity(GO:0001806) negative regulation of hypersensitivity(GO:0002884) |
0.2 | 0.7 | GO:0034760 | negative regulation of iron ion transport(GO:0034757) negative regulation of iron ion transmembrane transport(GO:0034760) |
0.2 | 0.2 | GO:0007521 | muscle cell fate determination(GO:0007521) |
0.1 | 0.4 | GO:0071846 | actin filament debranching(GO:0071846) |
0.1 | 0.6 | GO:1903237 | negative regulation of leukocyte tethering or rolling(GO:1903237) |
0.1 | 0.7 | GO:0045084 | positive regulation of interleukin-12 biosynthetic process(GO:0045084) |
0.1 | 0.8 | GO:0002430 | complement receptor mediated signaling pathway(GO:0002430) |
0.1 | 0.4 | GO:0001788 | antibody-dependent cellular cytotoxicity(GO:0001788) |
0.1 | 0.5 | GO:0035589 | G-protein coupled purinergic nucleotide receptor signaling pathway(GO:0035589) |
0.1 | 0.5 | GO:0010536 | positive regulation of activation of Janus kinase activity(GO:0010536) |
0.1 | 0.9 | GO:0061113 | pancreas morphogenesis(GO:0061113) |
0.1 | 0.5 | GO:0036022 | limb joint morphogenesis(GO:0036022) embryonic skeletal limb joint morphogenesis(GO:0036023) |
0.1 | 0.6 | GO:1903367 | positive regulation of fear response(GO:1903367) positive regulation of behavioral fear response(GO:2000987) |
0.1 | 0.6 | GO:0038165 | oncostatin-M-mediated signaling pathway(GO:0038165) |
0.1 | 0.6 | GO:0052151 | positive regulation by symbiont of host apoptotic process(GO:0052151) positive regulation of apoptotic process by virus(GO:0060139) |
0.1 | 0.4 | GO:0071608 | macrophage inflammatory protein-1 alpha production(GO:0071608) |
0.1 | 0.4 | GO:0014012 | peripheral nervous system axon regeneration(GO:0014012) |
0.1 | 0.3 | GO:0002344 | peripheral B cell selection(GO:0002343) B cell affinity maturation(GO:0002344) |
0.1 | 0.3 | GO:0097021 | lymphocyte migration into lymphoid organs(GO:0097021) |
0.1 | 0.3 | GO:0033634 | positive regulation of cell-cell adhesion mediated by integrin(GO:0033634) |
0.1 | 0.3 | GO:2000426 | regulation of MyD88-dependent toll-like receptor signaling pathway(GO:0034124) TRIF-dependent toll-like receptor signaling pathway(GO:0035666) interleukin-4-mediated signaling pathway(GO:0035771) response to interleukin-13(GO:0035962) cellular response to interleukin-13(GO:0035963) negative regulation of apoptotic cell clearance(GO:2000426) |
0.1 | 0.2 | GO:1903048 | regulation of acetylcholine-gated cation channel activity(GO:1903048) |
0.1 | 0.2 | GO:0002644 | negative regulation of tolerance induction(GO:0002644) |
0.1 | 0.3 | GO:0097029 | mature conventional dendritic cell differentiation(GO:0097029) |
0.1 | 0.2 | GO:0002355 | detection of tumor cell(GO:0002355) |
0.1 | 0.5 | GO:0030644 | cellular chloride ion homeostasis(GO:0030644) |
0.1 | 0.2 | GO:1902162 | regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:1902162) |
0.1 | 0.4 | GO:0033031 | positive regulation of neutrophil apoptotic process(GO:0033031) |
0.1 | 0.2 | GO:0009115 | xanthine catabolic process(GO:0009115) |
0.1 | 0.5 | GO:0043031 | negative regulation of macrophage activation(GO:0043031) |
0.1 | 0.1 | GO:1902523 | positive regulation of protein K63-linked ubiquitination(GO:1902523) |
0.1 | 0.3 | GO:0072592 | oxygen metabolic process(GO:0072592) |
0.1 | 0.2 | GO:0003275 | apoptotic process involved in outflow tract morphogenesis(GO:0003275) regulation of apoptotic process involved in outflow tract morphogenesis(GO:1902256) |
0.1 | 0.5 | GO:0045409 | negative regulation of interleukin-6 biosynthetic process(GO:0045409) |
0.1 | 0.4 | GO:0033153 | somatic diversification of T cell receptor genes(GO:0002568) somatic recombination of T cell receptor gene segments(GO:0002681) T cell receptor V(D)J recombination(GO:0033153) |
0.1 | 0.3 | GO:0006452 | translational frameshifting(GO:0006452) positive regulation of translational termination(GO:0045905) |
0.1 | 0.2 | GO:0031554 | regulation of DNA-templated transcription, termination(GO:0031554) |
0.0 | 0.1 | GO:0002408 | myeloid dendritic cell chemotaxis(GO:0002408) |
0.0 | 0.2 | GO:1990034 | calcium ion export from cell(GO:1990034) |
0.0 | 0.3 | GO:0006083 | acetate metabolic process(GO:0006083) short-chain fatty acid biosynthetic process(GO:0051790) |
0.0 | 0.4 | GO:0050861 | positive regulation of B cell receptor signaling pathway(GO:0050861) |
0.0 | 0.1 | GO:0046949 | fatty-acyl-CoA biosynthetic process(GO:0046949) malonyl-CoA metabolic process(GO:2001293) |
0.0 | 0.4 | GO:1903874 | ferrous iron transmembrane transport(GO:1903874) |
0.0 | 0.2 | GO:0035752 | lysosomal lumen pH elevation(GO:0035752) |
0.0 | 0.1 | GO:0010513 | phospholipase C-activating serotonin receptor signaling pathway(GO:0007208) positive regulation of phosphatidylinositol biosynthetic process(GO:0010513) |
0.0 | 0.6 | GO:0033004 | negative regulation of mast cell activation(GO:0033004) |
0.0 | 0.1 | GO:1905167 | positive regulation of lysosomal protein catabolic process(GO:1905167) |
0.0 | 0.1 | GO:0042450 | arginine biosynthetic process via ornithine(GO:0042450) |
0.0 | 0.5 | GO:0032570 | response to progesterone(GO:0032570) |
0.0 | 0.4 | GO:0060763 | mammary duct terminal end bud growth(GO:0060763) |
0.0 | 0.1 | GO:2000872 | positive regulation of progesterone secretion(GO:2000872) |
0.0 | 0.8 | GO:0035634 | response to stilbenoid(GO:0035634) |
0.0 | 0.1 | GO:0048550 | protein transport into plasma membrane raft(GO:0044861) negative regulation of pinocytosis(GO:0048550) |
0.0 | 0.1 | GO:0070375 | ERK5 cascade(GO:0070375) |
0.0 | 0.8 | GO:0045671 | negative regulation of osteoclast differentiation(GO:0045671) |
0.0 | 0.5 | GO:0090037 | positive regulation of protein kinase C signaling(GO:0090037) |
0.0 | 0.1 | GO:0061033 | secretion by lung epithelial cell involved in lung growth(GO:0061033) |
0.0 | 0.1 | GO:2000562 | negative regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000562) |
0.0 | 0.0 | GO:0010888 | negative regulation of lipid storage(GO:0010888) negative regulation of sequestering of triglyceride(GO:0010891) |
0.0 | 0.4 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
0.0 | 0.1 | GO:0042977 | regulation of activation of JAK2 kinase activity(GO:0010534) activation of JAK2 kinase activity(GO:0042977) negative regulation of activation of JAK2 kinase activity(GO:1902569) |
0.0 | 0.1 | GO:1902093 | thymocyte migration(GO:0072679) positive regulation of sperm motility(GO:1902093) |
0.0 | 0.4 | GO:2000042 | negative regulation of double-strand break repair via homologous recombination(GO:2000042) |
0.0 | 0.1 | GO:2000978 | negative regulation of forebrain neuron differentiation(GO:2000978) |
0.0 | 0.1 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
0.0 | 0.1 | GO:0046340 | diacylglycerol catabolic process(GO:0046340) |
0.0 | 0.3 | GO:0019243 | methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione(GO:0019243) methylglyoxal catabolic process(GO:0051596) methylglyoxal catabolic process to lactate(GO:0061727) |
0.0 | 0.4 | GO:0010745 | negative regulation of macrophage derived foam cell differentiation(GO:0010745) |
0.0 | 0.1 | GO:0046947 | hydroxylysine metabolic process(GO:0046946) hydroxylysine biosynthetic process(GO:0046947) |
0.0 | 0.2 | GO:0003219 | cardiac right ventricle formation(GO:0003219) |
0.0 | 0.1 | GO:0006436 | tryptophanyl-tRNA aminoacylation(GO:0006436) |
0.0 | 0.1 | GO:0043988 | histone H3-S28 phosphorylation(GO:0043988) |
0.0 | 0.1 | GO:0001992 | regulation of systemic arterial blood pressure by vasopressin(GO:0001992) |
0.0 | 0.2 | GO:0022417 | protein maturation by protein folding(GO:0022417) |
0.0 | 0.2 | GO:0043553 | negative regulation of phosphatidylinositol 3-kinase activity(GO:0043553) |
0.0 | 0.0 | GO:0007172 | signal complex assembly(GO:0007172) regulation of B cell chemotaxis(GO:2000537) positive regulation of B cell chemotaxis(GO:2000538) |
0.0 | 0.1 | GO:1903225 | negative regulation of endodermal cell differentiation(GO:1903225) |
0.0 | 0.2 | GO:0060024 | rhythmic synaptic transmission(GO:0060024) |
0.0 | 0.2 | GO:0007320 | insemination(GO:0007320) |
0.0 | 0.1 | GO:0014064 | positive regulation of serotonin secretion(GO:0014064) negative regulation of luteinizing hormone secretion(GO:0033685) |
0.0 | 0.1 | GO:0015851 | nucleobase transport(GO:0015851) pyrimidine nucleobase transport(GO:0015855) |
0.0 | 0.1 | GO:0061300 | cerebellum vasculature development(GO:0061300) |
0.0 | 0.2 | GO:0042435 | indole-containing compound biosynthetic process(GO:0042435) |
0.0 | 0.1 | GO:0006049 | UDP-N-acetylglucosamine catabolic process(GO:0006049) |
0.0 | 0.1 | GO:0031580 | membrane raft polarization(GO:0001766) membrane raft distribution(GO:0031580) |
0.0 | 0.3 | GO:1902715 | positive regulation of interferon-gamma secretion(GO:1902715) |
0.0 | 0.1 | GO:0061589 | calcium activated phosphatidylserine scrambling(GO:0061589) |
0.0 | 0.1 | GO:0010898 | positive regulation of triglyceride catabolic process(GO:0010898) |
0.0 | 0.1 | GO:0042723 | thiamine metabolic process(GO:0006772) thiamine-containing compound metabolic process(GO:0042723) positive regulation of adenosine receptor signaling pathway(GO:0060168) |
0.0 | 0.1 | GO:0038044 | transforming growth factor-beta secretion(GO:0038044) |
0.0 | 0.2 | GO:0030035 | microspike assembly(GO:0030035) |
0.0 | 0.1 | GO:0036233 | glycine import(GO:0036233) |
0.0 | 0.3 | GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
0.0 | 0.4 | GO:0021794 | thalamus development(GO:0021794) |
0.0 | 0.1 | GO:0035437 | maintenance of protein localization in endoplasmic reticulum(GO:0035437) |
0.0 | 0.1 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
0.0 | 0.1 | GO:0090526 | regulation of gluconeogenesis involved in cellular glucose homeostasis(GO:0090526) |
0.0 | 0.1 | GO:0015820 | branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
0.0 | 0.3 | GO:0006699 | bile acid biosynthetic process(GO:0006699) |
0.0 | 0.1 | GO:0070459 | prolactin secretion(GO:0070459) |
0.0 | 0.4 | GO:0001967 | suckling behavior(GO:0001967) |
0.0 | 0.4 | GO:0097435 | fibril organization(GO:0097435) |
0.0 | 0.0 | GO:0046619 | optic placode formation involved in camera-type eye formation(GO:0046619) |
0.0 | 0.2 | GO:0070995 | NADPH oxidation(GO:0070995) |
0.0 | 0.1 | GO:2000491 | positive regulation of hepatic stellate cell activation(GO:2000491) |
0.0 | 0.1 | GO:0006680 | glucosylceramide catabolic process(GO:0006680) positive regulation of phospholipid catabolic process(GO:0060697) |
0.0 | 0.1 | GO:2000189 | positive regulation of cholesterol homeostasis(GO:2000189) |
0.0 | 0.1 | GO:0002517 | T cell tolerance induction(GO:0002517) |
0.0 | 0.2 | GO:1904322 | response to forskolin(GO:1904321) cellular response to forskolin(GO:1904322) |
0.0 | 0.5 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
0.0 | 0.1 | GO:0021776 | smoothened signaling pathway involved in ventral spinal cord interneuron specification(GO:0021775) smoothened signaling pathway involved in spinal cord motor neuron cell fate specification(GO:0021776) |
0.0 | 0.3 | GO:0001516 | prostaglandin biosynthetic process(GO:0001516) prostanoid biosynthetic process(GO:0046457) |
0.0 | 0.0 | GO:2000016 | negative regulation of determination of dorsal identity(GO:2000016) |
0.0 | 0.2 | GO:0060501 | positive regulation of epithelial cell proliferation involved in lung morphogenesis(GO:0060501) |
0.0 | 0.0 | GO:0071651 | positive regulation of chemokine (C-C motif) ligand 5 production(GO:0071651) |
0.0 | 0.1 | GO:0043973 | histone H3-K4 acetylation(GO:0043973) |
0.0 | 0.0 | GO:0006562 | proline catabolic process(GO:0006562) |
0.0 | 0.0 | GO:0051977 | lysophospholipid transport(GO:0051977) positive regulation of arachidonic acid secretion(GO:0090238) |
0.0 | 0.1 | GO:0070474 | positive regulation of uterine smooth muscle contraction(GO:0070474) |
0.0 | 0.1 | GO:0070253 | somatostatin secretion(GO:0070253) |
0.0 | 0.0 | GO:0010593 | negative regulation of lamellipodium assembly(GO:0010593) |
0.0 | 0.1 | GO:0042590 | antigen processing and presentation of exogenous peptide antigen via MHC class I(GO:0042590) |
0.0 | 0.2 | GO:0002495 | antigen processing and presentation of peptide antigen via MHC class II(GO:0002495) |
0.0 | 0.1 | GO:0007296 | vitellogenesis(GO:0007296) |
0.0 | 0.2 | GO:0050765 | negative regulation of phagocytosis(GO:0050765) |
0.0 | 0.0 | GO:0002322 | B cell proliferation involved in immune response(GO:0002322) |
0.0 | 0.3 | GO:0045662 | negative regulation of myoblast differentiation(GO:0045662) |
0.0 | 0.0 | GO:1902938 | trans-synaptic signaling by lipid(GO:0099541) trans-synaptic signaling by endocannabinoid(GO:0099542) trans-synaptic signaling by lipid, modulating synaptic transmission(GO:0099552) trans-synaptic signaling by endocannabinoid, modulating synaptic transmission(GO:0099553) regulation of intracellular calcium activated chloride channel activity(GO:1902938) |
0.0 | 0.4 | GO:0042832 | defense response to protozoan(GO:0042832) |
0.0 | 0.1 | GO:0030206 | chondroitin sulfate biosynthetic process(GO:0030206) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 0.6 | GO:0032280 | symmetric synapse(GO:0032280) |
0.1 | 0.6 | GO:0042629 | mast cell granule(GO:0042629) |
0.0 | 0.1 | GO:0033596 | TSC1-TSC2 complex(GO:0033596) |
0.0 | 0.5 | GO:0001931 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.0 | 0.1 | GO:0034685 | integrin alphav-beta6 complex(GO:0034685) |
0.0 | 0.2 | GO:0034751 | aryl hydrocarbon receptor complex(GO:0034751) |
0.0 | 0.1 | GO:0005588 | collagen type V trimer(GO:0005588) |
0.0 | 0.4 | GO:0020005 | symbiont-containing vacuole membrane(GO:0020005) |
0.0 | 0.1 | GO:0070820 | tertiary granule(GO:0070820) |
0.0 | 0.5 | GO:0035631 | CD40 receptor complex(GO:0035631) |
0.0 | 0.3 | GO:0097433 | dense body(GO:0097433) |
0.0 | 0.3 | GO:0005642 | annulate lamellae(GO:0005642) |
0.0 | 0.3 | GO:0042612 | MHC class I protein complex(GO:0042612) |
0.0 | 0.1 | GO:0097233 | lamellar body membrane(GO:0097232) alveolar lamellar body membrane(GO:0097233) |
0.0 | 0.1 | GO:0042720 | mitochondrial inner membrane peptidase complex(GO:0042720) |
0.0 | 0.3 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.0 | 0.6 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
0.0 | 0.2 | GO:0042613 | MHC class II protein complex(GO:0042613) |
0.0 | 0.1 | GO:0000836 | ER ubiquitin ligase complex(GO:0000835) Hrd1p ubiquitin ligase complex(GO:0000836) |
0.0 | 0.3 | GO:0043205 | microfibril(GO:0001527) fibril(GO:0043205) |
0.0 | 0.2 | GO:0070852 | cell body fiber(GO:0070852) |
0.0 | 0.3 | GO:0005751 | mitochondrial respiratory chain complex IV(GO:0005751) |
0.0 | 0.1 | GO:0000308 | cytoplasmic cyclin-dependent protein kinase holoenzyme complex(GO:0000308) |
0.0 | 0.2 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.0 | 0.1 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
0.0 | 0.4 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.0 | 0.3 | GO:0030057 | desmosome(GO:0030057) |
0.0 | 0.1 | GO:0002177 | manchette(GO:0002177) |
0.0 | 0.1 | GO:0097524 | sperm plasma membrane(GO:0097524) |
0.0 | 0.7 | GO:0045335 | phagocytic vesicle(GO:0045335) |
0.0 | 0.4 | GO:0035861 | site of double-strand break(GO:0035861) |
0.0 | 0.1 | GO:1903440 | calcitonin family receptor complex(GO:1903439) amylin receptor complex(GO:1903440) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.4 | 3.1 | GO:0050786 | RAGE receptor binding(GO:0050786) |
0.2 | 0.6 | GO:0035717 | chemokine (C-C motif) ligand 7 binding(GO:0035717) |
0.2 | 1.3 | GO:0004556 | alpha-amylase activity(GO:0004556) |
0.1 | 0.8 | GO:0035662 | Toll-like receptor 4 binding(GO:0035662) |
0.1 | 0.4 | GO:0004060 | arylamine N-acetyltransferase activity(GO:0004060) |
0.1 | 0.3 | GO:0042015 | interleukin-20 binding(GO:0042015) |
0.1 | 0.7 | GO:0019957 | C-C chemokine binding(GO:0019957) |
0.1 | 0.7 | GO:0001515 | opioid peptide activity(GO:0001515) |
0.1 | 0.3 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
0.1 | 0.6 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
0.1 | 0.3 | GO:0030116 | glial cell-derived neurotrophic factor receptor binding(GO:0030116) |
0.1 | 0.3 | GO:0050220 | prostaglandin-D synthase activity(GO:0004667) prostaglandin-E synthase activity(GO:0050220) |
0.1 | 0.4 | GO:0019770 | IgG receptor activity(GO:0019770) |
0.1 | 1.0 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.1 | 0.4 | GO:0061649 | ubiquitinated histone binding(GO:0061649) |
0.1 | 0.3 | GO:0030023 | extracellular matrix constituent conferring elasticity(GO:0030023) |
0.1 | 0.4 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
0.1 | 0.2 | GO:0008147 | structural constituent of bone(GO:0008147) |
0.1 | 0.2 | GO:0036004 | GAF domain binding(GO:0036004) |
0.1 | 0.2 | GO:0004854 | xanthine dehydrogenase activity(GO:0004854) oxidoreductase activity, acting on CH or CH2 groups, NAD or NADP as acceptor(GO:0016726) |
0.1 | 0.3 | GO:0008381 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
0.1 | 0.3 | GO:0097001 | ceramide binding(GO:0097001) |
0.1 | 1.1 | GO:0042288 | MHC class I protein binding(GO:0042288) |
0.0 | 1.2 | GO:0071949 | FAD binding(GO:0071949) |
0.0 | 0.3 | GO:0015091 | ferric iron transmembrane transporter activity(GO:0015091) trivalent inorganic cation transmembrane transporter activity(GO:0072510) |
0.0 | 0.5 | GO:0001608 | G-protein coupled nucleotide receptor activity(GO:0001608) G-protein coupled purinergic nucleotide receptor activity(GO:0045028) |
0.0 | 0.1 | GO:0016964 | alpha-2 macroglobulin receptor activity(GO:0016964) |
0.0 | 0.4 | GO:0046934 | phosphatidylinositol-4,5-bisphosphate 3-kinase activity(GO:0046934) phosphatidylinositol bisphosphate kinase activity(GO:0052813) |
0.0 | 0.4 | GO:0046977 | TAP binding(GO:0046977) |
0.0 | 0.3 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
0.0 | 0.1 | GO:0016743 | carboxyl- or carbamoyltransferase activity(GO:0016743) |
0.0 | 0.1 | GO:0003989 | acetyl-CoA carboxylase activity(GO:0003989) |
0.0 | 0.4 | GO:1990405 | protein antigen binding(GO:1990405) |
0.0 | 0.1 | GO:0008475 | procollagen-lysine 5-dioxygenase activity(GO:0008475) |
0.0 | 4.5 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.0 | 0.1 | GO:0004830 | tryptophan-tRNA ligase activity(GO:0004830) |
0.0 | 0.2 | GO:0004118 | cGMP-stimulated cyclic-nucleotide phosphodiesterase activity(GO:0004118) |
0.0 | 0.3 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
0.0 | 1.0 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
0.0 | 0.1 | GO:0036313 | phosphatidylinositol 3-kinase catalytic subunit binding(GO:0036313) |
0.0 | 0.3 | GO:0042287 | MHC protein binding(GO:0042287) |
0.0 | 0.3 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.0 | 0.1 | GO:0015056 | corticotrophin-releasing factor receptor activity(GO:0015056) corticotropin-releasing hormone receptor activity(GO:0043404) |
0.0 | 0.1 | GO:0042134 | rRNA primary transcript binding(GO:0042134) |
0.0 | 0.1 | GO:0003827 | alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity(GO:0003827) |
0.0 | 0.1 | GO:0034481 | N-acetylglucosamine 6-O-sulfotransferase activity(GO:0001517) chondroitin sulfotransferase activity(GO:0034481) |
0.0 | 0.2 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
0.0 | 0.1 | GO:0005111 | type 2 fibroblast growth factor receptor binding(GO:0005111) |
0.0 | 0.1 | GO:0070540 | stearic acid binding(GO:0070540) |
0.0 | 0.5 | GO:0004890 | GABA-A receptor activity(GO:0004890) |
0.0 | 0.1 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
0.0 | 0.8 | GO:0017171 | serine hydrolase activity(GO:0017171) |
0.0 | 0.1 | GO:0070976 | TIR domain binding(GO:0070976) |
0.0 | 0.1 | GO:0015501 | glutamate:sodium symporter activity(GO:0015501) |
0.0 | 0.1 | GO:0015205 | purine nucleobase transmembrane transporter activity(GO:0005345) pyrimidine nucleobase transmembrane transporter activity(GO:0005350) nucleobase transmembrane transporter activity(GO:0015205) glycerol channel activity(GO:0015254) |
0.0 | 0.1 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
0.0 | 0.1 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
0.0 | 0.2 | GO:0042166 | acetylcholine binding(GO:0042166) |
0.0 | 1.1 | GO:0019003 | GDP binding(GO:0019003) |
0.0 | 0.1 | GO:0004769 | steroid delta-isomerase activity(GO:0004769) |
0.0 | 0.3 | GO:0016290 | palmitoyl-CoA hydrolase activity(GO:0016290) |
0.0 | 0.3 | GO:0016641 | oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor(GO:0016641) |
0.0 | 0.3 | GO:0017070 | U6 snRNA binding(GO:0017070) |
0.0 | 0.1 | GO:0050733 | RS domain binding(GO:0050733) |
0.0 | 0.1 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
0.0 | 0.1 | GO:0016936 | galactoside binding(GO:0016936) |
0.0 | 0.2 | GO:0015187 | glycine transmembrane transporter activity(GO:0015187) |
0.0 | 0.1 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
0.0 | 0.1 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
0.0 | 0.3 | GO:0030247 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
0.0 | 0.1 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
0.0 | 0.1 | GO:0051378 | serotonin binding(GO:0051378) |
0.0 | 0.0 | GO:0000995 | transcription factor activity, core RNA polymerase III binding(GO:0000995) |
0.0 | 0.0 | GO:0016979 | lipoate-protein ligase activity(GO:0016979) |
0.0 | 0.6 | GO:0030544 | Hsp70 protein binding(GO:0030544) |
0.0 | 0.3 | GO:0004129 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.0 | 0.2 | GO:0070330 | aromatase activity(GO:0070330) |
0.0 | 0.5 | GO:0016860 | intramolecular oxidoreductase activity(GO:0016860) |
0.0 | 0.3 | GO:0001222 | transcription corepressor binding(GO:0001222) |
0.0 | 0.1 | GO:0003995 | acyl-CoA dehydrogenase activity(GO:0003995) |
0.0 | 0.0 | GO:0005333 | norepinephrine transmembrane transporter activity(GO:0005333) |
0.0 | 0.1 | GO:0097643 | amylin receptor activity(GO:0097643) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 2.3 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.0 | 2.0 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.0 | 0.5 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.0 | 0.7 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.0 | 0.6 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.0 | 0.7 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.0 | 0.2 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
0.0 | 0.6 | PID IL3 PATHWAY | IL3-mediated signaling events |
0.0 | 0.4 | PID MYC PATHWAY | C-MYC pathway |
0.0 | 0.4 | SA TRKA RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
0.0 | 0.3 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.0 | 0.5 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.0 | 0.5 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.0 | 0.2 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.0 | 0.2 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.0 | 0.1 | PID ALK2 PATHWAY | ALK2 signaling events |
0.0 | 0.3 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 0.6 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
0.1 | 0.8 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
0.1 | 0.6 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
0.0 | 0.3 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
0.0 | 0.7 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.0 | 0.5 | REACTOME P2Y RECEPTORS | Genes involved in P2Y receptors |
0.0 | 0.8 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.0 | 0.4 | REACTOME THE NLRP3 INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
0.0 | 0.2 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
0.0 | 1.0 | REACTOME PHASE1 FUNCTIONALIZATION OF COMPOUNDS | Genes involved in Phase 1 - Functionalization of compounds |
0.0 | 0.5 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
0.0 | 0.4 | REACTOME INITIAL TRIGGERING OF COMPLEMENT | Genes involved in Initial triggering of complement |
0.0 | 0.1 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
0.0 | 0.2 | REACTOME PRESYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Presynaptic nicotinic acetylcholine receptors |
0.0 | 0.6 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
0.0 | 0.3 | REACTOME CD28 DEPENDENT VAV1 PATHWAY | Genes involved in CD28 dependent Vav1 pathway |
0.0 | 0.2 | REACTOME REGULATION OF THE FANCONI ANEMIA PATHWAY | Genes involved in Regulation of the Fanconi anemia pathway |
0.0 | 0.2 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
0.0 | 0.3 | REACTOME PTM GAMMA CARBOXYLATION HYPUSINE FORMATION AND ARYLSULFATASE ACTIVATION | Genes involved in PTM: gamma carboxylation, hypusine formation and arylsulfatase activation |
0.0 | 0.4 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
0.0 | 0.7 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.0 | 0.2 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
0.0 | 0.1 | REACTOME ACTIVATION OF CHAPERONE GENES BY ATF6 ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
0.0 | 0.1 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
0.0 | 1.6 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |
0.0 | 0.1 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
0.0 | 0.2 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
0.0 | 0.1 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |